Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongjun Zhang

Showing results (311-320 of 316) with videos related to

Pageof 32
Sort By:
You have reached the last page of results.This site can display upto 316 results.
ACS Medicinal Chemistry Letters|July 24, 2018
Discovery of MK-8318, a Potent and Selective CRTh2 Receptor Antagonist for the Treatment of AsthmaXianhai Huang, Jason Brubaker, Wei Zhou, et al.
ACS Medicinal Chemistry Letters|April 22, 2022
Diminishing GSH-Adduct Formation of Tricyclic Diazepine-based Mutant IDH1 InhibitorsChunhui Huang, Christian Fischer, Michelle R Machacek, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2021
SAR towards indoline and 3-azaindoline classes of IDO1 inhibitorsWensheng Yu, Yongqi Deng, Brett Hopkins, et al.
Journal of Medicinal Chemistry|March 3, 2022
Oxetane Promise Delivered: Discovery of Long-Acting IDO1 Inhibitors Suitable for Q3W Oral or Parenteral DosingDerun Li, David L Sloman, Abdelghani Achab, et al.
ACS Medicinal Chemistry Letters|March 19, 2021
Carbamate and <i>N</i>-Pyrimidine Mitigate Amide Hydrolysis: Structure-Based Drug Design of Tetrahydroquinoline IDO1 InhibitorsDerun Li, Yongqi Deng, Abdelghani Achab, et al.
Frontiers in Pharmacology|April 14, 2022
A Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)Xiaotong Li, Qingbian Ma, Jia Yin, et al.
Pageof 32

Showing results (311-320 of 316) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 316 results.
ACS Medicinal Chemistry Letters|July 24, 2018
Discovery of MK-8318, a Potent and Selective CRTh2 Receptor Antagonist for the Treatment of AsthmaXianhai Huang, Jason Brubaker, Wei Zhou, et al.
ACS Medicinal Chemistry Letters|April 22, 2022
Diminishing GSH-Adduct Formation of Tricyclic Diazepine-based Mutant IDH1 InhibitorsChunhui Huang, Christian Fischer, Michelle R Machacek, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2021
SAR towards indoline and 3-azaindoline classes of IDO1 inhibitorsWensheng Yu, Yongqi Deng, Brett Hopkins, et al.
Journal of Medicinal Chemistry|March 3, 2022
Oxetane Promise Delivered: Discovery of Long-Acting IDO1 Inhibitors Suitable for Q3W Oral or Parenteral DosingDerun Li, David L Sloman, Abdelghani Achab, et al.
ACS Medicinal Chemistry Letters|March 19, 2021
Carbamate and <i>N</i>-Pyrimidine Mitigate Amide Hydrolysis: Structure-Based Drug Design of Tetrahydroquinoline IDO1 InhibitorsDerun Li, Yongqi Deng, Abdelghani Achab, et al.
Frontiers in Pharmacology|April 14, 2022
A Clinical Practice Guideline for the Emergency Management of Anaphylaxis (2020)Xiaotong Li, Qingbian Ma, Jia Yin, et al.
Pageof 32